Phoenix Biotech Acquisition Corp
NASDAQ:CERO

Watchlist Manager
Phoenix Biotech Acquisition Corp Logo
Phoenix Biotech Acquisition Corp
NASDAQ:CERO
Watchlist
Price: 0.075 USD -1.32%
Market Cap: 1.6m USD

Intrinsic Value

The intrinsic value of one CERO stock under the Base Case scenario is 0.158 USD. Compared to the current market price of 0.075 USD, Phoenix Biotech Acquisition Corp is Undervalued by 52%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CERO Intrinsic Value
0.158 USD
Undervaluation 52%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Phoenix Biotech Acquisition Corp

What is Valuation History?
Ask AI Assistant
What other research platforms think about CERO?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CERO valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Phoenix Biotech Acquisition Corp.

Explain Valuation
Compare CERO to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CERO?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Phoenix Biotech Acquisition Corp

Current Assets 4.2m
Cash & Short-Term Investments 3.8m
Other Current Assets 443.9k
Non-Current Assets 2m
PP&E 1.5m
Other Non-Current Assets 499.9k
Current Liabilities 7.6m
Accounts Payable 6.4m
Accrued Liabilities 1.2m
Other Current Liabilities 105.5k
Non-Current Liabilities 218.3k
Other Non-Current Liabilities 218.3k
Efficiency

Free Cash Flow Analysis
Phoenix Biotech Acquisition Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Phoenix Biotech Acquisition Corp

Revenue
0 USD
Operating Expenses
-16.2m USD
Operating Income
-16.2m USD
Other Expenses
-25.7m USD
Net Income
-41.9m USD
Fundamental Scores

CERO Profitability Score
Profitability Due Diligence

Phoenix Biotech Acquisition Corp's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROIC
Exceptional ROE
ROIC is Increasing
60/100
Profitability
Score

Phoenix Biotech Acquisition Corp's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

CERO Solvency Score
Solvency Due Diligence

Phoenix Biotech Acquisition Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
42/100
Solvency
Score

Phoenix Biotech Acquisition Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CERO Price Targets Summary
Phoenix Biotech Acquisition Corp

There are no price targets for CERO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Phoenix Biotech Acquisition Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for CERO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CERO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CERO stock?

The intrinsic value of one CERO stock under the Base Case scenario is 0.158 USD.

Is CERO stock undervalued or overvalued?

Compared to the current market price of 0.075 USD, Phoenix Biotech Acquisition Corp is Undervalued by 52%.

Back to Top